WallachBeth Capital Starts DepoMed Inc (DEPO) at Buy
Tweet Send to a FriendGet Alerts DEPO Hot Sheet
Price: $5.84 -3.31%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade DEPO Now!
Earlier, WallachBeth Capital initiated coverage on DepoMed Inc (NASDAQ: DEPO) with a Buy rating and $8 price target.
Analyst Difei Yang expects the company turn profitable in 2013 and with shares trading at just ~2.5x sales, low for the group. Management is strong and its product portfolio has good patent protection and they see limited competition.
Yang the most interesting near term opportunities are Gralise, Glumetza and Zipsor, which combined are expected to drive revenue growth of 93% in 2013. "If approved by the FDA, Serada could drive growth in 2014 and beyond," the analyst comments.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $5.17 yesterday, with a 52 week range of $4.20-$7.15.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst Difei Yang expects the company turn profitable in 2013 and with shares trading at just ~2.5x sales, low for the group. Management is strong and its product portfolio has good patent protection and they see limited competition.
Yang the most interesting near term opportunities are Gralise, Glumetza and Zipsor, which combined are expected to drive revenue growth of 93% in 2013. "If approved by the FDA, Serada could drive growth in 2014 and beyond," the analyst comments.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $5.17 yesterday, with a 52 week range of $4.20-$7.15.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Depomed (DEPO) Reports Submission of ANDA for Generic Zipsor
- UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
- Goldman Sachs Starts Quintiles (Q) at Neutral
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
